These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

588 related items for PubMed ID: 22258486

  • 1. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
    Manetti M, Guiducci S, Romano E, Bellando-Randone S, Conforti ML, Ibba-Manneschi L, Matucci-Cerinic M.
    Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
    [Abstract] [Full Text] [Related]

  • 2. Elevated matrix metalloproteinase-9 in patients with systemic sclerosis.
    Kim WU, Min SY, Cho ML, Hong KH, Shin YJ, Park SH, Cho CS.
    Arthritis Res Ther; 2005 Jun; 7(1):R71-9. PubMed ID: 15642145
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
    Yanaba K, Komura K, Kodera M, Matsushita T, Hasegawa M, Takehara K, Sato S.
    Ann Rheum Dis; 2006 Jan; 65(1):124-6. PubMed ID: 16344498
    [Abstract] [Full Text] [Related]

  • 6. Bronchoalveolar matrix metalloproteinase 9 relates to restrictive lung function impairment in systemic sclerosis.
    Andersen GN, Nilsson K, Pourazar J, Hackett TL, Kazzam E, Blomberg A, Waldenström A, Warner J, Rantapää-Dahlqvist S, Mincheva-Nilsson L, Sandström T.
    Respir Med; 2007 Oct; 101(10):2199-206. PubMed ID: 17643278
    [Abstract] [Full Text] [Related]

  • 7. Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis.
    Hasegawa M, Sato S, Echigo T, Hamaguchi Y, Yasui M, Takehara K.
    Ann Rheum Dis; 2005 Jan; 64(1):21-8. PubMed ID: 15608300
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance of serum levels of matrix metalloproteinase-13 in patients with systemic sclerosis.
    Asano Y, Ihn H, Kubo M, Jinnin M, Mimura Y, Ashida R, Tamaki K.
    Rheumatology (Oxford); 2006 Mar; 45(3):303-7. PubMed ID: 16278285
    [Abstract] [Full Text] [Related]

  • 9. Elevated MMP-7 levels in patients with systemic sclerosis: correlation with pulmonary involvement.
    Moinzadeh P, Krieg T, Hellmich M, Brinckmann J, Neumann E, Müller-Ladner U, Kreuter A, Dumitrescu D, Rosenkranz S, Hunzelmann N.
    Exp Dermatol; 2011 Sep; 20(9):770-3. PubMed ID: 21707759
    [Abstract] [Full Text] [Related]

  • 10. Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls.
    Young-Min SA, Beeton C, Laughton R, Plumpton T, Bartram S, Murphy G, Black C, Cawston TE.
    Ann Rheum Dis; 2001 Sep; 60(9):846-51. PubMed ID: 11502611
    [Abstract] [Full Text] [Related]

  • 11. Increased alveolar concentration of nitric oxide is related to serum-induced lung fibroblast proliferation in patients with systemic sclerosis.
    Hua-Huy T, Tiev KP, Chéreau C, Duong-Quy S, Cabane J, Dinh-Xuan AT.
    J Rheumatol; 2010 Aug 01; 37(8):1680-7. PubMed ID: 20595271
    [Abstract] [Full Text] [Related]

  • 12. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis.
    Yamaguchi Y, Ono J, Masuoka M, Ohta S, Izuhara K, Ikezawa Z, Aihara M, Takahashi K.
    Br J Dermatol; 2013 Apr 01; 168(4):717-25. PubMed ID: 23110679
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.
    Sato S, Komura K, Hasegawa M, Fujimoto M, Takehara K.
    J Rheumatol; 2001 Nov 01; 28(11):2460-5. PubMed ID: 11708419
    [Abstract] [Full Text] [Related]

  • 14. Elevated serum concentrations of triggering receptor expressed on myeloid cells-1 in diffuse cutaneous systemic sclerosis: association with severity of pulmonary fibrosis.
    Tomita H, Ogawa F, Hara T, Yanaba K, Iwata Y, Muroi E, Yoshizaki A, Komura K, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S.
    J Rheumatol; 2010 Apr 01; 37(4):787-91. PubMed ID: 20156945
    [Abstract] [Full Text] [Related]

  • 15. Serum CXCL16 concentrations correlate with the extent of skin sclerosis in patients with systemic sclerosis.
    Yanaba K, Muroi E, Yoshizaki A, Hara T, Ogawa F, Shimizu K, Yozaki M, Hasegawa M, Fujimoto M, Takehara K, Sato S.
    J Rheumatol; 2009 Sep 01; 36(9):1917-23. PubMed ID: 19605674
    [Abstract] [Full Text] [Related]

  • 16. Increased serum pentraxin 3 in patients with systemic sclerosis.
    Iwata Y, Yoshizaki A, Ogawa F, Komura K, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Takehara K, Sato S.
    J Rheumatol; 2009 May 01; 36(5):976-83. PubMed ID: 19273457
    [Abstract] [Full Text] [Related]

  • 17. Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis.
    Taniguchi T, Asano Y, Akamata K, Noda S, Masui Y, Yamada D, Takahashi T, Ichimura Y, Toyama T, Tamaki Z, Tada Y, Sugaya M, Kadono T, Sato S.
    J Rheumatol; 2012 Mar 01; 39(3):539-44. PubMed ID: 22247367
    [Abstract] [Full Text] [Related]

  • 18. Correlation of serum collagen I carboxyterminal telopeptide concentrations with cutaneous and pulmonary involvement in systemic sclerosis.
    Allanore Y, Borderie D, Lemaréchal H, Cherruau B, Ekindjian OG, Kahan A.
    J Rheumatol; 2003 Jan 01; 30(1):68-73. PubMed ID: 12508392
    [Abstract] [Full Text] [Related]

  • 19. Serum interleukin 9 levels are increased in patients with systemic sclerosis: association with lower frequency and severity of pulmonary fibrosis.
    Yanaba K, Yoshizaki A, Asano Y, Kadono T, Sato S.
    J Rheumatol; 2011 Oct 01; 38(10):2193-7. PubMed ID: 21807780
    [Abstract] [Full Text] [Related]

  • 20. Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
    Vancheeswaran R, Magoulas T, Efrat G, Wheeler-Jones C, Olsen I, Penny R, Black CM.
    J Rheumatol; 1994 Oct 01; 21(10):1838-44. PubMed ID: 7837147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.